Proteoglycans are promising therapeutic targets in Multiple Sclerosis (MS), because they regulate many aspects of the immune response. This was studied using surfen, an agent that binds both heparan sulphate p…

Read More...

Leave a comment.

Your email address will not be published. Required fields are marked*

Andoird App
Loading...